Oxford Immunotec
(OXFD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 187,291 | 189,518 | 192,844 | 70,156 | 66,263 |
| Receivables | 22,893 | 14,715 | 13,658 | 7,080 | 19,742 |
| Inventories | 9,957 | 9,944 | 7,767 | 6,114 | 9,835 |
| Other current assets | 0 | 0 | 0 | 31,899 | 0 |
| TOTAL | $223,340 | $218,215 | $216,780 | $118,206 | $99,928 |
| Non-Current Assets | |||||
| PPE Net | 6,658 | 7,066 | 7,144 | 6,428 | 12,712 |
| Intangibles | 2,533 | 2,539 | 2,544 | 3,441 | 11,488 |
| Other Non-Current Assets | 9,500 | 13,490 | 5,652 | 1,085 | 1,816 |
| TOTAL | $18,691 | $23,095 | $15,340 | $10,954 | $26,016 |
| Total Assets | $242,031 | $241,310 | $232,120 | $129,160 | $125,944 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,519 | 3,115 | 2,886 | 33,885 | 4,280 |
| Accrued Expenses | 9,227 | 9,377 | 10,891 | 10,189 | 9,754 |
| Other current liabilities | 4,289 | 4,130 | 4,106 | 8,891 | 4,451 |
| TOTAL | $16,729 | $17,319 | $18,008 | $52,996 | $18,531 |
| Non-Current Liabilities | |||||
| Long Term Debt | 30 | 30 | 106 | 97 | 30,136 |
| Deferred Revenues | 214 | 213 | 125 | 31 | 46 |
| Other Non-Current Liabilities | 7,489 | 7,782 | 0 | 4,101 | 4,113 |
| TOTAL | $7,519 | $7,812 | $106 | $4,198 | $34,249 |
| Total Liabilities | $24,248 | $25,131 | $18,114 | $57,194 | $52,780 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,831 | 26,623 | 26,617 | 26,361 | 25,968 |
| Common Shares | 280 | 278 | 276 | 276 | 272 |
| Retained earnings | -81,668 | -82,258 | -80,762 | -221,822 | -218,338 |
| Other shareholders' equity | -8,711 | -7,356 | -8,523 | -7,290 | -6,676 |
| TOTAL | $217,783 | $216,179 | $214,006 | $71,966 | $73,164 |
| Total Liabilities And Equity | $242,031 | $241,310 | $232,120 | $129,160 | $125,944 |